Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Myocet Plus Endoxan for Older Patients With Breast Cancer

This study has been terminated.
(Due to poor accrual)
Sponsor:
Information provided by (Responsible Party):
Hellenic Oncology Research Group
ClinicalTrials.gov Identifier:
NCT01120171
First received: May 5, 2010
Last updated: October 6, 2015
Last verified: October 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: May 2015
  Primary Completion Date: May 2015 (Final data collection date for primary outcome measure)